Neurohumoral mechanisms in hypertension

Angiology
|January 1, 1975
PubMed

Insights

This study explores catecholamines and neurohumoral mechanisms in hypertension. It details diagnostic approaches for pheochromocytoma and discusses altered norepinephrine and epinephrine levels in essential hypertension.

Area of Science:

  • Cardiovascular Physiology
  • Endocrinology
  • Neuropharmacology

Background:

  • Hypertension involves complex neurohumoral mechanisms.
  • Catecholamines, including norepinephrine and epinephrine, play a critical role in blood pressure regulation.
  • Understanding these mechanisms is crucial for diagnosing and managing hypertensive diseases.

Purpose of the Study:

  • To discuss neurohumoral mechanisms involving catecholamines in hypertensive diseases.
  • To differentiate catecholamine involvement in pheochromocytoma, labile essential hypertension, and established essential hypertension.
  • To explore the sympathetic nervous system's role in other hypertensive conditions.

Main Methods:

  • Review of existing literature on catecholamine pathways in hypertension.
  • Analysis of diagnostic criteria for pheochromocytoma based on urinary catecholamine metabolites.
  • Examination of plasma catecholamine levels and reactivity in different hypertensive states.

Main Results:

  • Pheochromocytoma diagnosis relies on urinary catecholamine metabolites; invasive procedures should be minimized.
  • Established essential hypertension shows increased norepinephrine reactivity and plasma levels, with decreased uptake and secretion.
  • Labile essential hypertension exhibits increased epinephrine reactivity and plasma levels, with decreased uptake.

Conclusions:

  • Neurohumoral catecholamine dysregulation is central to various hypertensive diseases.
  • Distinct patterns of catecholamine alterations characterize pheochromocytoma and essential hypertension subtypes.
  • The sympathetic nervous system and angiotensin II interact in complex hypertensive conditions, including renovascular hypertension and hyperaldosteronism.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...